PRESOLICITATION NOTICE
A -- Enzyme Linked Immunoassays of Soluable Receptors and Infused Monoclonal Antibodies
- Notice Date
- 12/10/2001
- Notice Type
- Presolicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Room 604, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- N02-RC-27020-30
- Response Due
- 2/15/2002
- Archive Date
- 3/2/2002
- Point of Contact
- Elsa Carlton, Contracting Officer, Phone (301) 435-3811, Fax (301) 402-6699,
- E-Mail Address
-
ec39g@nih.gov
- Description
- ELECTRONIC RFP ANNOUNCEMENT. THIS RFP MAY BE ACCESSED THROUGH THE RESEARCH CONTRACTS BRANCH (RCB) HOMEPAGE AT http://rcb.nci.nih.gov/ INTERESTED OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE RFP SOLICITATION AND AMENDMENTS, IF ANY. The Metabolism Branch (MB), Center for Cancer Research (CCR), National Cancer Institute (NCI) is soliciting proposals for performance of enzyme-linked immunoassays of soluable receptors, infused monoclonal antibodies, and antibodies produced to the therapeutically infused monoclonals in human serum and/or tissue culture media. An offeror must meet the following Mandatory Qualification Criteria at the time of receipt of Final Proposal Revisions (FPR) by the Contracting Officer in order for your proposal to be considered any further for award: (1) demonstrate how you will accomplish the task of attendance at frequent face-to-face discussions between the NCI Project Officer, and the Project Director, and other key personnel in Bethesda, MD, in order to monitor and review progress on project activities; (2) demonstrate how you will accomplish the task of picking-up samples from Bethesda, MD, perform the assays, and provide a written report of the results of the assays within a maximum of twenty-four (24) hours from the time of pick-up; and (3) have biocontainment facilities (BL-2) to conduct work in vivo with human and nonhuman primate viruses (HTLV-I and SIV). This solicitation is a re-competition of N02-SC-71003 with Covance Laboratories, Inc. This RFP N02-RC-27020-30 will be issued, electronically, on or about January 15, 2002, after publication of this notice. Proposals will be due approximately 30 days after the issue date. No collect calls will be accepted.
- Place of Performance
- Address: National Institutes of Health, National Cancer Institute, Bethesda, MD 20892
- Record
- SN20011210/00002254-011211095412 (fbodaily.com)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |